Abstract: Compounds of the formula
W, Q, R1, R2 and R10 are as defined in the specification. A process for their preparation and pharmaceutical compositions and methods of treatment involving their use in the treatment of respiratory disease including, for example, asthma, are also provided.
Type:
Grant
Filed:
November 8, 2000
Date of Patent:
October 23, 2001
Assignee:
AstraZeneca AB
Inventors:
Martin E Cooper, David R Cheshire, David K Donald, Mark Furber, Matthew W. D Perry, Richard P Harrison, Nicholas P Tomkinsson